New State Capital Partners Closes Fund IV at $700 Million
Fund IV attracted a diverse investor base, including endowments and foundations, family offices, public pension plans, insurance companies, OCIOs, and high-net-worth individuals across
"This milestone underscores the trust investors have in our strategy and our platform." said
New State has completed more than 45 acquisitions to date. The firm leverages a differentiated sourcing model, including strong relationships with the independent sponsor community, designed to identify attractive investment opportunities. The depth and breadth of New State's team ensures hands-on support to drive portfolio company growth.
New State's 34-person team includes 12 management company partners and a dedicated 10-person in-house operations team, providing deep experience and operational knowledge. The firm recently added to its capabilities with three strategic hires: a Vice President on the Investment Team, a Senior Principal focused on strategy, and an Operating Partner specializing in revenue growth, further enhancing its ability to support portfolio companies and drive value creation.
Kirkland & Ellis LLP served as fund counsel, and Harris Williams Private Capital Advisory Ltd. served as placement agent.
About New State Capital Partners
New State Capital Partners is an entrepreneurial-minded private equity firm that strives to be nimble, decisive, and cooperative. The Firm takes a long-term approach, partnering with company founders and independent sponsors in an effort to create lasting value. New State seeks to invest in market-leading, middle market companies with services-based business models and has completed over 45 acquisitions to date. For more information, visit www.newstatecp.com.
Media Contact:
Lambert by LLYC
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-state-capital-partners-closes-fund-iv-at-700-million-302403912.html
SOURCE New State Capital Partners LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI Visitors Convert to Sign-Ups at 11x the Rate of Search Traffic, Yet Most Analytics Platforms Can't See Them, Rankability Analysis Finds
- FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
- 22,000 UNIVERSITY OF CALIFORNIA TEAMSTERS RATIFY STRONGEST CONTRACT EVER
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share